Skip to main content
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2026 Mar 5;17:1812769. doi: 10.3389/fimmu.2026.1812769

Correction: Immune-related adverse events associated with nab-paclitaxel/paclitaxel combined with immune checkpoint inhibitors: a systematic review and network meta-analysis

Wenjing Hao 1, Jun Zhang 1, Yunxia Wang 1, Boyu Fang 1, Shasha Jin 1, Jing Yuan 2,*, Weimin Cai 1,*
PMCID: PMC13000430  PMID: 41869318

In the published article, there was an error in the Funding statement. “This work was supported by grant from the National Natural Science Foundation of China [Grant No. 8217130423]”.

The correct Funding statement appears below.

“This work was supported by grant from the National Natural Science Foundation of China [Grant No. 82173892]“

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

The original article has been updated.

Footnotes

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES